RSI integrates cumulative and aggregate exposure modeling into broader risk characterization efforts, using a systems-based lens and data-driven tools. Its team uses default and custom scenarios grounded in population behavior and environmental distribution data. RSI ensures that outputs are scientifically sound, policy-aligned, and transparent in assumptions. This method enables RSI to provide nuanced, realistic exposure profiles that can inform public health, chemical safety, and environmental regulation.

The Financial Consumer Agency of Canada (FCAC) engaged Risk Sciences International to provide strategic advisory services aimed at enhancing its regulatory compliance model through risk-based methodologies. FCAC’s objective was to explore new approaches that would integrate digital tools and data-driven strategies into its compliance activities, in line with its strategic goal of strengthening consumer protection in financial markets.

RSI includes tacit knowledge workshops in its assessments when working with frontline workers, community members, or multi-sectoral collaborators. The firm uses techniques such as journey mapping, moderated storytelling, and artifact elicitation to draw out hidden insights. RSI integrates these insights into decision support tools and qualitative syntheses, enhancing the depth and relevance of its Understanding Risk methods.

The societal risk aspects of chemical safety have become a focal point of concern for the public, governments, and the chemical industry. This concern stems from the increasing awareness of the vast number of chemicals present in everyday life, such as in household products, foods, and workplaces. Some of these chemicals have been linked to…

RSI emphasizes process documentation in all engagements, producing structured protocols, audit trails, and technical appendices. The firm’s standardized templates support consistency across projects while allowing customization to client needs. This method ensures RSI’s work can be verified, explained, and transferred across teams or jurisdictions.

Registration form for the Canadian Recipient Hemovigilance System Renewal Consensus Conference to be held both in Toronto and online via MS Teams on 23/24 March 2026. Overview: The Canadian Recipient Hemovigilance System renewal process seeks to design a renewed, effective, and sustainable national system that enables Canada to better detect, analyse, and learn from transfusion-related…

In response to public and ministerial concerns about the timeliness and adequacy of information shared during a major prescription drug recall, Health Canada commissioned an independent review to assess its response to the event. The situation involved a recall of the oral contraceptive Alysena, issued due to packaging issues that altered the intended dosing sequence and raised questions about potential unintended health risks.

There is no excerpt because this is a protected post.